Top Premarket Gainers-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Top Premarket Gainers

Aug 5, 2025 4:52 AM

07:36 AM EDT, 08/05/2025 (MT Newswires) -- Arteris ( AIP ) shares were 64% high pre-bell Tuesday, a day after the company said that AMD (AMD) has licensed its FlexGen network-on-chip interconnect IP.

STAAR Surgical ( STAA ) stock was up 44% after the company agreed to be acquired by Alcon (ALC) for about $1.5 billion.

Castle Biosciences ( CSTL ) shares were 24% higher after the company said Monday it raised its 2025 revenue guidance to $310 million to $320 million from the previous guidance range of $287 million to $297 million.

Primoris Services ( PRIM ) stock was up 20%, a day after the company posted stronger Q2 financial results and lifted its 2025 guidance.

Previous page： Taiwan's FPCC shuts Mailiao refinery port after quake, sources say Next page： Genmab to Acquire ProfoundBio for $1.8 Billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Taiwan's FPCC shuts Mailiao refinery port after quake, sources say

Apr 3, 2024

SINGAPORE, April 3 (Reuters) - Taiwan's Formosa Petrochemical (FPCC) has stopped operations at its port at the Mailiao refinery as a precautionary measure following a powerful earthquake, two people with knowledge of the matter said. The company is expected to resume operations at the port on Wednesday at around 3 p.m. (0700 GMT), one of the sources said. There could...

Genmab to Acquire ProfoundBio for $1.8 Billion

Apr 3, 2024

03:21 AM EDT, 04/03/2024 (MT Newswires) -- Genmab ( GMAB ) agreed to acquire privately owned biotechnology company ProfoundBio in an all-cash deal worth $1.8 billion, the companies said in a joint statement on Wednesday. The acquisition will give Genmab ( GMAB ) worldwide rights to ProfoundBio's portfolio of antibody-drug conjugates, comprising three candidates in clinical development, including rinatabart sesutecan,...

Japanese trading house Itochu expects 10% higher profit this financial year

Apr 3, 2024

TOKYO (Reuters) - Japanese trading house Itochu ( ITOCF ) on Wednesday forecast a 10% rise in its net profit to 880 billion yen ($5.8 billion) this financial year, from an estimated 800 billion yen a year earlier, and expected a shareholder return ratio of 50%. Unveiling its new management plan for the 2024/25 financial year that started on April...

International Flavors & Fragrances Completes Sale of Cosmetic Ingredients Business to Clariant

Apr 3, 2024

03:24 AM EDT, 04/03/2024 (MT Newswires) -- International Flavors & Fragrances ( IFF ) said Wednesday it completed the sale of its cosmetic ingredients business to Clariant. In October, IFF agreed to sell the business to the specialty chemicals company for $810 million. ...